MEDICINES
LAB TESTS
CONSULT DOCTORS
CANCER CARE
AYURVEDA
PARTNERSHIPS
CARE PLAN
Login
|
Signup
Offers
Order Summary
0 Item
PROCEED TO CART
Need Help?
Location IconGPS icon
QUICK BUY! Get 25% off on medicines*
Emtricitabine + Tenofovir Alafenamide
INFORMATION ABOUT EMTRICITABINE + TENOFOVIR ALAFENAMIDE
Emtricitabine + Tenofovir Alafenamide Uses
Emtricitabine+Tenofovir Alafenamide is used in the treatment of HIV infection.
How Emtricitabine + Tenofovir Alafenamide works
Emtricitabine + Tenofovir Alafenamide is a combination of two medicines, emtricitabine and tenofovir alafenamide. They belong to a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Emtricitabine interrupts the virus life cycle by inhibiting a crucial enzyme called HIV-1 reverse transcriptase. Tenofovir alafenamide is converted to tenofovir diphosphate which gets incorporated into viral DNA, resulting in the inhibition of HIV replication.
Common side effects of Emtricitabine + Tenofovir Alafenamide
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common
Nausea, Diarrhea, Headache, Depression, Rash, Dizziness, Fatigue, Vomiting, Insomnia (difficulty in sleeping), Weakness, Allergic reaction, Abnormal dreams, Decreased phosphate level in blood, Decreased white blood cell count (neutrophils), Increased triglyceride level in blood, Abdominal pain, Weight loss, Upper respiratory tract infection, Increased transaminase level in blood, Increased glucose level in blood, Elevated levels of serum amylase, Increased lipase in the blood, Elevated creatine kinase
CONTENT DETAILS
Written By
Dr. Anuj Saini
MMST, MBBS
Reviewed By
Dr. Rajeev Sharma
MBA, MBBS
Last updated
19 May 2023 | 03:51 PM (UTC)
We provide you with authentic, trustworthy and revelant information
Read our editorial policy
Medicine brands for Emtricitabine + Tenofovir Alafenamide
Expert advice for Emtricitabine + Tenofovir Alafenamide
  • Emtricitabine + Tenofovir Alafenamide may weaken your bones. Exercise regularly and take calcium and vitamin D supplements as suggested by your doctor.
  • Although treatment with Emtricitabine + Tenofovir Alafenamide can reduce the risk of you passing HIV to others through sexual contact, it does not stop it. Therefore, it is important to use condoms.
  • Inform your doctor immediately if you develop any infection soon after taking Emtricitabine + Tenofovir Alafenamide.
  • Your doctor may prescribe you blood tests to check for hepatitis B virus infection before the start of the treatment with Emtricitabine + Tenofovir Alafenamide.
  • Increase your fluid intake and take a healthy diet during your treatment with Emtricitabine + Tenofovir Alafenamide.
  • Avoid sharing personal belongings like razors or toothbrushes with your family members.
  • It is common for people with HIV to feel low or even depressed, especially soon after the diagnosis has been made. If you have any feelings of depression it is advisable to speak with your doctor.
Frequently asked questions for Emtricitabine + Tenofovir Alafenamide
Emtricitabine+Tenofovir Alafenamide is a combination of two medicines that belong to a group of medicines called antiretrovirals. It is used to treat HIV (human immunodeficiency virus), the virus that can cause AIDS (acquired immunodeficiency syndrome). It helps to control HIV infection so your immune system can work better.
One tablet of Emtricitabine+Tenofovir Alafenamide orally once daily with or without food is to be taken by adults and pediatric patients 12 years of age and older. Always follow your doctor's instructions while taking this medicine and never self-medicate.
No, Emtricitabine+Tenofovir Alafenamide is not recommended for patients with severe kidney disease (creatinine clearance below 30 mL/minute). Your doctor will be able to give you more information on this.
No, Emtricitabine+Tenofovir Alafenamide is not approved for the treatment of chronic HBV infection, and the safety and efficacy of the medicine have not been established in patients coinfected with HIV-1 and HBV infection. Thus, patients with HIV-1 will be tested for the presence of chronic hepatitis B virus (HBV) before initiating antiretroviral therapy with Emtricitabine+Tenofovir Alafenamide.
Yes, $ the name may cause your bones to get weak and brittle. You will be prescribed a bone mineral density test if you have a history of bone fracture or disorders like osteoporosis.
Yes, you may experience flu infections after taking Emtricitabine+Tenofovir Alafenamide since your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Immediately consult your doctor if you notice any changes in your health.
No, Emtricitabine+Tenofovir Alafenamide will not stop HIV transmission to your partner during sex. Make sure you understand this and practice safe sex, even if your partner also has HIV, by using a latex condom or other barrier methods. Seek advice from your doctor.